InsidersTradesSigma
Follow the Neurizon Therapeutics Limited share price and the full insider trade history of the company, a listed issuer based in Australia. Shares trade on the AU market, under the supervision of ASX. Operating in the Health Care sector, Neurizon Therapeutics Limited has logged 2 insider filings. Market capitalisation: €52.7m. The latest transaction was filed on 12 May 2026 (Other). Among the most active insiders: Dr. Michael Thurn. All data is accessible without an account.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,940 of 28,832 companies
25.4
score / 100
Value7
Quality44
FCF yld-31%
Earn yld-36%
EV/EBITDA·
ROE-147%
Gross mgn72%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 May 2026
Declarations2 total
ShareASXISIN AU0000357261ASX:2924-03089281-6A1325154
●
11ASX ↗
ShareASXISIN AU0000357261ASX:2924-03089273-6A1325148
2 of 2 declarations
About Neurizon Therapeutics Limited
Neurizon Therapeutics Limited is a company focused on developing innovative treatments for neurological disorders. It is listed on the XASX market.